🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07174791
Active, not recruiting Not applicable

Fully Versus Partially Guided Implants Placement: Measurement of Accuracy of Implant Position and Passivity of Superstructures.

NCT07174791 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-01-15
Last updated
2025-09-16

Condition(s) studied

Completely EdentulousImplant Assesment

Investigational drug(s) / intervention(s)

cone beam computed tomographyphotogrammetric scan using elite scanner (shining 3d)

cone beam computed tomography: -Implant marginal bone height changes will be measured by cone beam radiograph after one and two years of loading

photogrammetric scan using elite scanner (shining 3d): implant placement accuracy will be evaluated using photogrammetric scan after implant insertion

Study summary

compare fully versus partially guided all on four implants placement immediately loaded by maxillary and mandibular screw retained overdentures: A radiographic and photogrammetric measurement of accuracy of implant position and passivity of superstructures.

The measurements will be done as follows:

1. Photogrammetric scan immediately after implant instalments to measure 3D accuracy of implant position and Passivity of super structure
2. Cone beam X ray to measure the implant marginal bone height changes.
3. Implant marginal soft tissue evaluations including pocket probing depth, plaque and gingival indices. Evaluation will be done immediately, one and two years after loading.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Completely healed residual alveolar ridges * Angle's class I maxillo-mandibular relationship. * Sufficient mandibular and maxillary restorative spaces, at least 15mm evaluated by recording a tentative jaw relation. * Adequate bone height in the premaxilla area, and the anterior mandibular area. - This will be evaluated radiographically Exclusion Criteria: * Systemic disorders affecting bone (such as uncontrolled diabetes mellitus and osteoporosis). * Local or general contraindication for surgical procedures. * History of chemotherapy or radiation therapy to the head and neck area. * Poor neuromuscular co-ordination. * TMJ dysfunction and parafunctional habits

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mansoura University, Faculty of Dentistry, mansoura, egypt Al Mansurah Mansoura

More Mansoura University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07174791 on ClinicalTrials.gov ↗ ← All trials in Egypt